AU673265B2 - Treatment process with biologically active tropane derivatives - Google Patents

Treatment process with biologically active tropane derivatives Download PDF

Info

Publication number
AU673265B2
AU673265B2 AU67671/94A AU6767194A AU673265B2 AU 673265 B2 AU673265 B2 AU 673265B2 AU 67671/94 A AU67671/94 A AU 67671/94A AU 6767194 A AU6767194 A AU 6767194A AU 673265 B2 AU673265 B2 AU 673265B2
Authority
AU
Australia
Prior art keywords
group
aryltropane
uptake
hydrogen
derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU67671/94A
Other languages
English (en)
Other versions
AU6767194A (en
Inventor
Barbara Bennett
Steven R Childers
Huw M.L. Davies
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wake Forest University
Original Assignee
Wake Forest University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/063,431 external-priority patent/US6008227A/en
Application filed by Wake Forest University filed Critical Wake Forest University
Publication of AU6767194A publication Critical patent/AU6767194A/en
Application granted granted Critical
Publication of AU673265B2 publication Critical patent/AU673265B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/468-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Emergency Medicine (AREA)
  • Psychiatry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU67671/94A 1993-05-18 1994-04-04 Treatment process with biologically active tropane derivatives Ceased AU673265B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/063,431 US6008227A (en) 1992-03-13 1993-05-18 Process for blocking 5-HT and dopamine uptake with biologically active tropane derivatives
US063431 1993-05-18
PCT/US1994/003661 WO1994026274A1 (fr) 1993-05-18 1994-04-04 Therapie faisant appel a des derives biologiquement actifs du tropane

Publications (2)

Publication Number Publication Date
AU6767194A AU6767194A (en) 1994-12-12
AU673265B2 true AU673265B2 (en) 1996-10-31

Family

ID=22049138

Family Applications (1)

Application Number Title Priority Date Filing Date
AU67671/94A Ceased AU673265B2 (en) 1993-05-18 1994-04-04 Treatment process with biologically active tropane derivatives

Country Status (5)

Country Link
EP (1) EP0697871A4 (fr)
JP (1) JP2906085B2 (fr)
AU (1) AU673265B2 (fr)
CA (1) CA2163095A1 (fr)
WO (1) WO1994026274A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0859777T3 (da) * 1995-10-13 2007-09-03 Neurosearch As 8-azabicyclo[3.2.1]oct-2-en-derivater, deres fremstilling og anvendelse
US7105678B2 (en) 1995-11-03 2006-09-12 Organix, Inc. Boat tropanes
CA2721484A1 (fr) * 1999-05-12 2000-11-12 President And Fellows Of Harvard College Agents d'imagerie pour transporteur de dopamine
GB9920074D0 (en) * 1999-08-24 1999-10-27 Babraham Inst Animal model and uses thereof
US7459464B2 (en) * 2002-05-30 2008-12-02 Neurosearch A/S Triple monoamine reuptake inhibitors for the treatment of chronic pain
WO2007028770A1 (fr) * 2005-09-05 2007-03-15 Neurosearch A/S Inhibiteurs du recaptage du neurotransmetteur monoamine pour une neuroprotection chez des patients souffrant d'une maladie mentale avancée

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU668721B2 (en) * 1992-03-13 1996-05-16 Wake Forest University Biologically active tropane derivatives

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3813404A (en) * 1972-11-15 1974-05-28 Sterling Drug Inc Tropane-2-carboxylates and derivatives
US5288872A (en) * 1992-03-13 1994-02-22 Wake Forest University Compounds for treatment of neurodegenerative diseases
AU672052B2 (en) * 1992-12-23 1996-09-19 Neurosearch A/S Antidepressant and antiparkinsonian compounds

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU668721B2 (en) * 1992-03-13 1996-05-16 Wake Forest University Biologically active tropane derivatives

Also Published As

Publication number Publication date
CA2163095A1 (fr) 1994-11-24
EP0697871A4 (fr) 1998-04-22
JPH08510238A (ja) 1996-10-29
WO1994026274A1 (fr) 1994-11-24
AU6767194A (en) 1994-12-12
EP0697871A1 (fr) 1996-02-28
JP2906085B2 (ja) 1999-06-14

Similar Documents

Publication Publication Date Title
US6008227A (en) Process for blocking 5-HT and dopamine uptake with biologically active tropane derivatives
US5763455A (en) Biologically active tropane derivatives
Meltzer et al. The discovery of an unusually selective and novel cocaine analog: difluoropine. Synthesis and inhibition of binding at cocaine recognition sites
AU657996B2 (en) Novel medical use for tachykinin antagonists
CA2284732C (fr) Analogues de cocaine
CA2309434A1 (fr) Nouveaux derives de 4-arylpiperidine pour le traitement du prurit
HUT65771A (en) Process for producing substituted 3-amino-quinuclidine derivatives and pharmaceutical compositions containing them
HU214321B (hu) Eljárás tramadol-N-oxid-származék, enantiomerjei és ezeket hatóanyagként tartalmazó gyógyszerkészítmények előállítására
AU2017202849C1 (en) Potent and Selective Inhibitors of Monoamine Transporters; Method of Making; and Use Thereof
AU673265B2 (en) Treatment process with biologically active tropane derivatives
WO2001044193A1 (fr) Analogues de piperidine 1,3,4-substituee et leurs utilisations dans le traitement de la toxicomanie
JPH06507616A (ja) 新規ヘテロ環状カルボン酸
JP2877231B2 (ja) スピロキヌクリジン誘導体の光学異性体、それらの製造法、それらからなる薬剤組成物およびそれらを使用した治療法
CA1261841A (fr) Medicaments a base de derives de (quinolyl-4)-1 (piperidyl-4)-2 ethanol ou (quinolyl-4)-1 (piperidyl-4)-3 propanol
TW215090B (fr)
JPH01313477A (ja) トランス‐ヘキサヒドロ‐8‐ヒドロキシ‐2,6‐メタノ‐2h‐キノリジン‐3(4h)‐オンのインドール‐3‐カルボン酸エステル類の製法
US6013242A (en) Tropane derivatives with selective binding to the serotonin reuptake transporters for treatment of mental illness and as intermediates in the formation of imaging diagnostic agents for depression
Ivanovic et al. 3-Carbomethoxy fentanyl: Synthesis, pharmacology and conformational analysis
JP2009529534A (ja) 中枢神経系活動に用いられるホモトロパン
US4233449A (en) 1-(8-Methyl-2-phenyl(or thienyl)-8-azabicyclo[3.2.1]octan-3-yl) ethanone
Zhang et al. Synthesis of dopamine transporter selective 3-diarylmethoxymethyl-8-arylalkyl-8-azabicyclo [3.2. 1] octane derivatives
US4281130A (en) Lower-alkyl 4,6,7,8,8a-9-hexahydro-6,9-ethanothieno[3,2-f]indolizine-10-carboxylate
CN1035765C (zh) 六氢化-8-羟基-2,6-亚甲基-2h-喹嗪-3(4h)-酯的制备方法
JPH02215782A (ja) 新規化合物、その製法及びそれを含む医薬組成物
AU2001286561B2 (en) 2-3-disubstituted quinuclidines as modulators of monoamine transporters and therapeutic and diagnostic methods based thereon

Legal Events

Date Code Title Description
MK14 Patent ceased section 143(a) (annual fees not paid) or expired